anti-Chemokine (C-C Motif) Ligand 13 (CCL13) 抗体产品概述

Full name:
anti-Chemokine (C-C Motif) Ligand 13 抗体 (CCL13)
在www.antibodies-online.cn可供115 Chemokine (C-C Motif) Ligand 13 (CCL13) 抗体的16不同的供货商。 再加上,我们可以发Chemokine (C-C Motif) Ligand 13 试剂盒 (44)Chemokine (C-C Motif) Ligand 13 蛋白 (37)和数多这个蛋白质的别的产品。 总共202 Chemokine (C-C Motif) Ligand 13产品已列进来了。
CKb10, Mcp-4, Mcp4, MMCP-4, MMCP-4A, MMCP-4B, NCC-1, NCC1, SCYA13, SCYL1
列出全部抗体 基因 基因ID UniProt
CCL13 6357 Q99616
CCL13 17227 P21812



最受欢迎的抗anti-Chemokine (C-C Motif) Ligand 13 (CCL13) 抗体


抗Human 抗体:

抗Mouse (Murine) 抗体:

抗Rat (Rattus) 抗体:

所有可销售的anti-Chemokine (C-C Motif) Ligand 13 抗体


引用最多的anti-Chemokine (C-C Motif) Ligand 13 抗体

  1. Human Polyclonal CCL13 Primary Antibody for WB - ABIN2792189 : Kalayci, Birben, Wu, Oguma, Storm Vans Gravesande, Subramaniam, Sheldon, Silverman, Lilly: Monocyte chemoattractant protein-4 core promoter genetic variants: influence on YY-1 affinity and plasma levels. in American journal of respiratory cell and molecular biology 2003 (PubMed)

  2. Human Monoclonal CCL13 Primary Antibody for ELISA (Capture), FACS - ABIN4899862 : Gounni Abdelilah, Wellemans, Agouli, Guenounou, Hamid, Beck, Lamkhioued: Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines. in Clinical immunology (Orlando, Fla.) 2006 (PubMed)

更多抗Chemokine (C-C Motif) Ligand 13的相互作用对抗体

Human Chemokine (C-C Motif) Ligand 13 (CCL13) interaction partners

  1. CCL13 expression is significantly upregulated in human masticatory mucosa during wound healing

  2. The reduction of circulating levels of MCP-4, eotaxin-3 (显示 CCL26 抗体), and MIP-1beta (显示 CCL4 抗体) could be one of the mechanisms by which bariatric surgery contributes to the reduction of cardiovascular risk in these patients.

  3. CCL13 levels in serum and synovial fluid may serve as a biomarker for the progression of osteoarthritis.

  4. identified 13 ADCC-activated genes. Six gene expression assays including 8 of the 13 genes (CCL3 (显示 CCL3 抗体), CCL4/CCL4L1 (显示 CCL4 抗体)/CCL4L2, CD160 (显示 CD160 抗体), IFNG (显示 IFNG 抗体), NR4A3 (显示 NR4A3 抗体) and XCL1 (显示 XCL1 抗体)/XCL2 (显示 XCL2 抗体)) were analyzed in 127 kidney biopsies

  5. CCL13 is an antimicrobial protein with bacteriocidal activity against E. coli.

  6. Data suggest that CCL13 binds to several chemokine (显示 CCL1 抗体) receptors (CCR1, CCR2 (显示 CCR2 抗体), and CCR3 (显示 CCR3 抗体)), allowing CCL13 to elicit different effects on target cells of immune system. CCL13 is involved in pathology of chronic inflammatory/autoimmune diseases. [REVIEW]

  7. MCP-4 and hsCRP may be the markers linking chronic inflammation in obesity and periodontal disease.

  8. E(2) has adverse effects on the pathogenesis of RA as a result of unregulated cell death, increased TNF-alpha (显示 TNF 抗体)-induced MMP-3 (显示 MMP3 抗体) production, and CCL13 overproduction, subsequently resulting in the disease progression of RA.

  9. Data show that, for the small macrophages in COPD (显示 ARCN1 抗体), increased transcript and protein levels for CCL2 (显示 CCL2 抗体), CCL7 (显示 CCL7 抗体), CCL13 and CCL22 (显示 CCL22 抗体) with a more than 100-fold increase for CCL13 mRNA.

  10. Findings suggest that the pro-atherogenic effects of CCR2 (显示 CCR2 抗体) may not be restricted to interaction with MCP-1 (显示 CCL2 抗体), but could also involve activation by MCP-4, being an inflammatory link between platelet and monocyte activation.

Mouse (Murine) Chemokine (C-C Motif) Ligand 13 (CCL13) interaction partners

  1. deletion of the gene encoding MMCP-4 (Mcpt4), markedly reduced late, but not early, infarct size by suppressing IGF-1 (显示 IGF1 抗体) degradation and, consequently, diminished cardiac dysfunction and adverse structural remodeling

  2. Data indicate that a second-degree burn injury can initiate an immediate novel zonal degranulation of mast cell throughout all skin layers and a disruption of the epidermal tight junctions dependent on the nonredundant presence of mMCP4 and mMCP5 (显示 CMA1 抗体).

  3. these results support the conclusion that mast cells can contribute to the initial lung injury induced by bleomycin through release of the MCPT4 chymase (显示 CMA1 抗体).

  4. Mast cell chymase (显示 CMA1 抗体) degrades the alarmins heat shock protein 70 (显示 HSP70 抗体), biglycan (显示 BGN 抗体), HMGB1 (显示 HMGB1 抗体), and interleukin-33 (IL-33 (显示 IL33 抗体)) and limits danger-induced inflammation.

  5. Data from Mcp-4 (mast cell protease 4) knockout mice suggest Mcp-4 plays a pivotal role in the dynamic (in vivo and in vitro) conversion of systemic Big-endothelin-1 (显示 EDN1 抗体) to endothelin-1 (显示 EDN1 抗体) (1-31).

  6. MCs (显示 SMCP 抗体) exert protective functions after trauma, at least in part via mMCP-4, by suppressing exacerbated inflammation via their proteases.

  7. The effects of interactions between mMCP-4 and TNF (显示 TNF 抗体) in vivo by analyzing the features of a classic model of polymicrobial sepsis, were assessed.

  8. mMCP-4 plays two different roles in the pathogenesis of experimental BP, by both activating MMP-9 (显示 MMP9 抗体) and by cleaving BP180 (显示 COL17A1 抗体), leading to injury of the hemidesmosomes and extracellular matrix of the basement membrane zone.

  9. mMCP-4-deficient mice but not to mMCP-5 (显示 CMA1 抗体)-deficient mice revealing nonredundant actions for these two MC proteases in a model of innate inflammatory injury with remodeling.

  10. MCP-4 contributes locally to the aggravation of glomerulonephritis by mediating a variety of proinflammatory effects.

Chemokine (C-C Motif) Ligand 13 (CCL13) 抗原简介

Antigen Summary

This gene is one of several Cys-Cys (CC) cytokine genes clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. This chemokine plays a role in accumulation of leukocytes during inflammation. It may also be involved in the recruitment of monocytes into the arterial wall during artherosclerosis.

Alternative names and synonyms associated with Chemokine (C-C Motif) Ligand 13 (CCL13)

  • chemokine (C-C motif) ligand 13 (CCL13) 抗体
  • mast cell protease 4 (Mcpt4) 抗体
  • CKb10 抗体
  • Mcp-4 抗体
  • Mcp4 抗体
  • MMCP-4 抗体
  • MMCP-4A 抗体
  • MMCP-4B 抗体
  • NCC-1 抗体
  • NCC1 抗体
  • SCYA13 抗体
  • SCYL1 抗体

Protein level used designations for CCL13

C-C motif chemokine 13 , CK-beta-10 , monocyte chemoattractant protein 4 , monocyte chemotactic protein 4 , new CC chemokine 1 , small inducible cytokine subfamily A (Cys-Cys), member 13 , small-inducible cytokine A13 , monocyte chemotactic protein-4 , MSMCP , myonase , serosal mast cell protease

6357 Homo sapiens
445451 Canis lupus familiaris
17227 Mus musculus
anti-Chemokine (C-C Motif) Ligand 13 (CCL13) 抗体 精选生产商